Table of Contents page: Translational Research

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

CAR T-cell therapy for lung cancer and malignant pleural mesothelioma

Masha Zeltsman,
Jordan Dozier,
Erin McGee,
Daniel Ngai,
Prasad S. Adusumilli

Published online: April 26, 2017

p1-10

Development of novel antigen receptors for CAR T-cell therapy directed toward solid malignancies

David Chen,
James Yang

Published online: June 01, 2017

p11-21

Development of novel avenues to overcome challenges facing CAR T cells

Soyeon Kim,
Edmund K. Moon

Published online: June 09, 2017

p22-31

Chimeric antigen receptor–engineered natural killer and natural killer T cells for cancer immunotherapy

Dominique Bollino,
Tonya J. Webb

Published online: June 09, 2017

p32-43

Hemophilia A inhibitor treatment: the promise of engineered T-cell therapy

Kalpana Parvathaneni,
Maha Abdeladhim,
Kathleen P. Pratt,
David W. Scott

Published online: June 09, 2017

p44-52

Antigen-specific regulatory T cells: are police CARs the answer?

Nicholas A.J. Dawson,
Megan K. Levings

Published online: June 19, 2017

p53-58

Chimeric antigen receptor T-cells for B-cell malignancies

Eben I. Lichtman,
Gianpietro Dotti

Published online: June 28, 2017

p59-82

New approaches for the enhancement of chimeric antigen receptors for the treatment of HIV

Mayra A. Carrillo,
Anjie Zhen,
Jerome A. Zack,
Scott G. Kitchen

Published online: July 13, 2017

p83-92

Chimeric antigen receptor T-cell therapy for glioblastoma

Analiz Rodriguez,
Christine Brown,
Behnam Badie

Published online: July 14, 2017

p93-102

Information for Readers

Published in issue: September 2017

IBC

Masthead

Published in issue: September 2017

A1

Editorial Advisory Board

Published in issue: September 2017

A2-A3

Author Guidelines

Published in issue: September 2017

A4-A6

Latest

Popular Articles

Advances in therapeutic CRISPR/Cas9 genome editing

TMAO: how gut microbiota contributes to heart failure

Immune responses to injury and their links to eye disease

Latest Articles

POLYMERIZED HUMAN HEMOGLOBIN WITH LOW AND HIGH OXYGEN AFFINITY IN TRAUMA MODELS

Norcantharidin potentiates sorafenib antitumor activity in hepatocellular carcinoma rat model through inhibiting IL-6/STAT3 pathway

Microsatellite Instability in Non-Endometrioid Ovarian Epithelial Tumors: A study of 400 cases Comparing Immunohistochemistry, PCR, and NGS Based Testing with Mutation Status of MMR Genes.

For Authors

Journal Information

Access

Contact

Follow Us

September 2017

In-Depth Review: Chimeric Antigen Receptor T Cell-based Therapies

CAR T-cell therapy for lung cancer and malignant pleural mesothelioma

Development of novel antigen receptors for CAR T-cell therapy directed toward solid malignancies

Development of novel avenues to overcome challenges facing CAR T cells

Chimeric antigen receptor–engineered natural killer and natural killer T cells for cancer immunotherapy

Hemophilia A inhibitor treatment: the promise of engineered T-cell therapy

Antigen-specific regulatory T cells: are police CARs the answer?

Chimeric antigen receptor T-cells for B-cell malignancies

New approaches for the enhancement of chimeric antigen receptors for the treatment of HIV

Chimeric antigen receptor T-cell therapy for glioblastoma

Information for Readers

Contents

Frontmatter

Contents

Masthead

Editorial Advisory Board

Author Guidelines